ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

Varmus Wins ASCO’s Science Of Oncology Award; Sawyers To Give Karnofsky Lecture.

January 28, 2005

Cancer Meetings Listed For Next Three Months

June 25, 1993

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Afinitor Approved for Rare Disorder

November 5, 2010